As of 9:30 AM on the 8th, Celltrion is trading at 358,500 KRW, up 0.28% from the previous day. This represents a 7.5% increase compared to December 28. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Over the past five days, individual investors have net purchased 707,262 shares, while foreigners and institutions have net sold 385,088 shares and 336,586 shares, respectively.


On January 5, Celltrion was a market topic with the headline "Strong performance following the disclosure of Phase 2 clinical trial results for COVID-19 antibody treatment."



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing